Literature DB >> 3676601

Origin of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion and vagus nerve.

S J Ireland1.   

Abstract

1 5-Hydroxytryptamine (5-HT)-induced membrane potential changes were recorded extracellularly from rat superior cervical ganglia (SCG) and cervical vagus nerves in vitro. 2 On the SCG, low concentrations of 5-HT (1 X 10(-8)-3 X 10(-7) M) induced concentration-related hyperpolarization responses. Higher concentrations of 5-HT (1 X 10(-6) 1 X 10(-4) M) induced complex responses which typically consisted of an initial hyperpolarization, followed by a depolarization and subsequent after-hyperpolarization. The depolarization, but not the initial hyperpolarization, was blocked by metoclopramide (3 X 10(-5) M), quipazine (1 X 10(-6) M) or MDL 72222 (1 X 10(-5) M). 3 5-HT-induced hyperpolarization of the SCG was potentiated when the amount of calcium chloride added to the superfusion medium was reduced from 2.5 to 0.15 mmol l-1. Hyperpolarization responses recorded from SCG preparations superfused with this low-calcium medium were unaffected by the substitution of lithium chloride for sodium chloride and were potentiated by the omission of potassium ions. Ouabain (1 X 10(-3) M) abolished both the hyperpolarization and the depolarization induced by 5-HT. 4 On the vagus nerve, 5-HT (1 X 10(-7) - 3 X 10(-5)M) did not induce initial hyperpolarization in either normal or low-calcium Krebs-Henseleit medium. However, in the latter solution only, depolarization responses induced by 5-HT at concentrations of 1 X 10(-6)M or greater were followed by hyperpolarization. Both the depolarization and the post-5-HT hyperpolarization were blocked by metoclopramide (3 X 10(-5)M) but were unaffected by spiperone (1 X 10(-7)M). 5 On the vagus nerve, post-5-HT hyperpolarization responses were selectively and reversibly inhibited by ouabain, and by superfusion with Krebs-Henseleit medium that was either potassium-free or contained lithium chloride in place of sodium chloride. 7 These results demonstrate the generation in the rat SCG of a 5-HT-induced hyperpolarization response that is not mediated through 5-HT3 receptors and is unlikely to be a consequence of depolarization. In contrast, on the rat vagus nerve, the post-5-HT hyperpolarization observed in the present study had the characteristics expected of depolarization-dependent activation of a sodium ion pump.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3676601      PMCID: PMC1853653          DOI: 10.1111/j.1476-5381.1987.tb11337.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  On the permeability of mammalian non-myelinated fibres to sodium and to lithium ions.

Authors:  C J Armett; J M Ritchie
Journal:  J Physiol       Date:  1963-01       Impact factor: 5.182

2.  The ionic requirements for the action of acetylcholine on mammalian non-myelinated fibres.

Authors:  C J Armett; J M Ritchie
Journal:  J Physiol       Date:  1963-01       Impact factor: 5.182

3.  Some properties of the external activation site of the sodium pump in crab nerve.

Authors:  P F Baker; C M Connelly
Journal:  J Physiol       Date:  1966-07       Impact factor: 5.182

4.  5-HT hyperpolarization of bullfrog sympathetic ganglion cell membrane.

Authors:  S Watanabe; K Koketsu
Journal:  Experientia       Date:  1973-11-15

5.  Movements of labelled sodium ions in isolated rat superior cervical ganglia.

Authors:  D A Brown; C N Scholfield
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

6.  Cholinergic through-fibers in the rat superior cervical ganglion.

Authors:  O Sacchi; M L Rossi
Journal:  J Auton Nerv Syst       Date:  1981-06

7.  Depolarizing responses recorded from nodose ganglion cells of the rabbit evoked by 5-hydroxytryptamine and other substances.

Authors:  D I Wallis; C E Stansfeld; H L Nash
Journal:  Neuropharmacology       Date:  1982-01       Impact factor: 5.250

8.  Muscarinic receptors in rat sympathetic ganglia.

Authors:  D A Brown; S Fatherazi; J Garthwaite; R D White
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

9.  Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.

Authors:  S J Ireland; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

10.  Origin of the after-hyperpolarization that follows removal of depolarizing agents from the isolated superior cervical ganglion of the rat.

Authors:  D A Brown; M J Brownstein; C N Scholfield
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

View more
  6 in total

1.  The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.

Authors:  A Butler; C J Elswood; J Burridge; S J Ireland; K T Bunce; G J Kilpatrick; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.

Authors:  A Butler; J M Hill; S J Ireland; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

3.  Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.

Authors:  A B Hawcock; J C Barnes; A D Michel
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

4.  The depolarizing action of 5-hydroxytryptamine on rabbit isolated preganglionic cervical sympathetic nerves.

Authors:  P Elliott; D I Wallis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

5.  Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion.

Authors:  S J Ireland; C C Jordan
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

6.  A component of 5-HT-evoked depolarization of the rat isolated vagus nerve is mediated by a putative 5-HT4 receptor.

Authors:  K F Rhodes; J Coleman; N Lattimer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.